AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00JF231Y4
0.04▼ 0.01 (-14.58%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.05
Day's Range
0.04 – 0.05
52-Week Range
0.03 – 9.59
Volume
19.4M
Avg Volume
38.8M
Share Statistics
Shares Outstanding
Employees
75
Exchange
XNAS
Listed
2019-01-04
Share count as of March 31, 2026

China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about China SXT Pharmaceuticals, Inc. Class A Ordinary Shares (SXTC)
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Market Cap?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Market Cap is $39.3K, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Enterprise Value?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Enterprise Value is -$20.1M, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Price / Sales?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Price / Sales is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EV / Revenue?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EV / EBITDA?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EV / EBITDA is 2.4×, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Revenue (TTM)?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Revenue (TTM) is $1.5M, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Net Income (TTM)?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Net Income (TTM) is -$8.9M, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EBITDA?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EBITDA is -$8.3M, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Diluted EPS (TTM)?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's Diluted EPS (TTM) is -9.26, based on as-reported figures from SEC (XBRL) filings.
What is China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EBITDA Margin?
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares's EBITDA Margin is -542.0%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · SXTCAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019Mar 31, 2018
Revenues
YoY growth-34.6%
Cost of revenues
Gross profit
% of revenue21.9%
Operating expenses:
Selling and marketing
General and administrative
Total operating expenses
% of revenue-647.7%
Operating loss
% of revenue-625.9%
Other income (expenses):
Interest expenses, net
Other income (expenses), net
Total other income (expenses), net
Loss before income taxes
Income tax expenses—
Net loss
% of revenue-545.2%
Basic (in Dollars per share)
Diluted (in Dollars per share)